0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Special Articles   |    
Prazosin for Military Combat-Related PTSD Nightmares: A Critical Review
Brian W. Writer, D.O.; Eric G. Meyer, M.D.; Jason E. Schillerstrom, M.D.
The Journal of Neuropsychiatry and Clinical Neurosciences 2014;26:24-33. doi:10.1176/appi.neuropsych.13010006
View Author and Article Information

Disclaimer: The opinions expressed on this document are solely those of the authors and do not represent an endorsement by or the views of the United States Air Force, the Department of Defense, or the United States Government.

From the Dept. of Psychiatry, Wilford Hall Ambulatory Surgical Center, Joint Base San Antonio, TX.

Send correspondence to Dr Writer; e-mail: brian.writer@gmail.com

Copyright © 2014 by the American Psychiatric Association

Received January 15, 2013; Revised March 21, 2013; Accepted March 25, 2013.

Abstract

Military combat is a common trauma experience associated with posttraumatic stress disorder (PTSD). Trauma-related nightmares are a hallmark symptom of PTSD. They can be resistant to label-pharmacological PTSD treatment, and they are associated with a variety of adverse health outcomes. The purpose of this article is to review and evaluate prazosin therapy for combat-related PTSD nightmares. Consistent with available literature for all-causes PTSD nightmares, prazosin is an effective off-label option for combat-related PTSD nightmares. Future trials may further instruct use in specific combat-exposure profiles.

Abstract Teaser
Figures in this Article

Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Anchor for Jump
TABLE 1.Classification of Study Evidence28
Anchor for Jump
TABLE 2.Summary of Available Studies Examining Prazosin Efficacy for Military Combat-Related Nightmares
Table Footer Note

SD: standard deviation; ASD: Acute Stress Disorder; BSI: Behavioral Sleep Intervention; CAPS: Clinician-Administered Posttraumatic Stress Disorder Scale; CES: Combat Exposure Scale; CGI–C: Clinical Global Impression–Change; ISI: Insomnia Severity Index; NNDA: Non-Nightmare Distressed Awakenings; PghSD: Pittsburgh Sleep Diary; PSQI: Pittsburgh Sleep Quality Index; PSQI-A: PSQI Addendum for PTSD; SUD: Substance Use Disorder.

Anchor for Jump
TABLE 3.Common Primary Outcome Measures
Table Footer Note

CGI–C:32 1: markedly improved; 2: moderately improved; 3: minimally improved; 4: unchanged; 5: minimally worse; 6: moderately worse; 7: markedly worse.

+

References

American Psychiatric Association:  Diagnostic and Statistical Manual of Mental Disorders , 4th Edition, Text Revision.  Washington, DC,  American Psychiatric Association, 2000
 
Benedek  DM;  Ursano  RJ:  Posttraumatic Stress Disorder: From Phenomenology to Clinical Practice.  FOCUS: The Journal of Lifelong Learning in Psychiatry 2009; VII:160–175
 
Stern  TA;  Rosenbaum  JF;  Fava  M  et al:  Massachusetts General Hospital Comprehensive Clinical Psychiatry , 1st Edition.  Philadelphia, PA,  Mosby Elsevier, 2008, chap 34
 
Silver  JM;  McAllister  TW;  Yudofsky  SC:  Textbook of Traumatic Brain Injury , 2nd Edition.  Arlington,  VA,  American Psychiatric Publishing, 2011, chap 12
 
Klein  S;  Alexander  DA:  Epidemiology and presentation of post-traumatic disorders.  Psychiatry 2009; 8:282–287
[CrossRef]
 
Keane  TM;  Marshall  AD;  Taft  CT:  Posttraumatic stress disorder: etiology, epidemiology, and treatment outcome.  Annu Rev Clin Psychol 2006; 2:161–197
[CrossRef] | [PubMed]
 
Pietrzak  RH;  Goldstein  RB;  Southwick  SM  et al:  Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.  J Anxiety Disord 2011; 25:456–465
[CrossRef] | [PubMed]
 
Grieger  TA;  Cozza  SJ;  Ursano  RJ  et al:  Posttraumatic stress disorder and depression in battle-injured soldiers.  Am J Psychiatry 2006; 163:1777–1783; quiz 1860
[CrossRef] | [PubMed]
 
Smith  TC;  Ryan  MAK;  Wingard  DL  et al; Millennium Cohort Study Team:  New onset and persistent symptoms of post-traumatic stress disorder self-reported after deployment and combat exposures: prospective population-based U.S. military cohort study.  BMJ 2008; 336:366–371
[CrossRef] | [PubMed]
 
Andrews  B;  Brewin  CR;  Philpott  R  et al:  Delayed-onset posttraumatic stress disorder: a systematic review of the evidence.  Am J Psychiatry 2007; 164:1319–1326
[CrossRef] | [PubMed]
 
Lineberry  TW;  O’Connor  SS:  Suicide in the U.S. Army.  Mayo Clin Proc 2012; 87:871–878
[CrossRef] | [PubMed]
 
Leard-Mann  CA;  Smith  TC;  Smith  B  et al; Millennium Cohort Study Team:  Baseline self-reported functional health and vulnerability to post-traumatic stress disorder after combat deployment: prospective U.S. military cohort study.  BMJ 2009; 338:b1273
[CrossRef] | [PubMed]
 
Lydiard  RB;  Hamner  MH:  Clinical Importance of Sleep Disturbance as a Treatment Target in PTSD.  FOCUS The Journal of Lifelong Learning in Psychiatry 2009; VII:176–183
 
Levin  R;  Nielsen  TA:  Disturbed dreaming, posttraumatic stress disorder, and affect distress: a review and neurocognitive model.  Psychol Bull 2007; 133:482–528
[CrossRef] | [PubMed]
 
Calohan  J;  Peterson  K;  Peskind  ER  et al:  Prazosin treatment of trauma nightmares and sleep disturbance in soldiers deployed in Iraq.  J Trauma Stress 2010; 23:645–648
[CrossRef] | [PubMed]
 
Lamarche  LJ;  De Koninck  J:  Sleep disturbance in adults with posttraumatic stress disorder: a review.  J Clin Psychiatry 2007; 68:1257–1270
[CrossRef] | [PubMed]
 
Aurora  RN;  Zak  RS;  Auerbach  SH  et al; Standards of Practice Committee; American Academy of Sleep Medicine:  Best practice guide for the treatment of nightmare disorder in adults.  J Clin Sleep Med 2010; 6:389–401
[PubMed]
 
Raskind  MA;  Peskind  ER;  Hoff  DJ  et al:  A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder.  Biol Psychiatry 2007; 61:928–934
[CrossRef] | [PubMed]
 
Nappi  CM;  Drummond  SP;  Hall  JM:  Treating nightmares and insomnia in posttraumatic stress disorder: a review of current evidence.  Neuropharmacology 2012; 62:576–585
[CrossRef] | [PubMed]
 
Geracioti  TD  Jr;  Baker  DG;  Ekhator  NN  et al:  CSF norepinephrine concentrations in posttraumatic stress disorder.  Am J Psychiatry 2001; 158:1227–1230
[CrossRef] | [PubMed]
 
Benedek  DM;  Friedman  MJ;  Zatzick  D  et al:  Guideline Watch (March 2009): Practice Guideline for the Treatment of Patients with Acute Stress Disorder and Posttraumatic Stress Disorder.  FOCUS The Journal of Lifelong Learning in Psychiatry 2009; VII:204–213
 
Jeffreys  M;  Capehart  B;  Friedman  MJ:  Pharmacotherapy for posttraumatic stress disorder: review with clinical applications.  J Rehabil Res Dev 2012; 49:703–715
[CrossRef] | [PubMed]
 
Boehnlein  JK;  Kinzie  JD:  Pharmacologic reduction of CNS noradrenergic activity in PTSD: the case for clonidine and prazosin.  J Psychiatr Pract 2007; 13:72–78
[CrossRef] | [PubMed]
 
Raskind  MA;  Peskind  ER;  Kanter  ED  et al:  Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study.  Am J Psychiatry 2003; 160:371–373
[CrossRef] | [PubMed]
 
Taylor  FB;  Martin  P;  Thompson  C  et al:  Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study.  Biol Psychiatry 2008; 63:629–632
[CrossRef] | [PubMed]
 
Graham  RL;  Leckband  SG;  Endow-Eyer  RA:  PTSD nightmares: Prazosin and atypical antipsychotics.  Current Psychiatry 2012; 11:59–62
 
Kung  S;  Espinel  Z;  Lapid  MI:  Treatment of nightmares with prazosin: a systematic review.  Mayo Clin Proc 2012; 87:890–900
[CrossRef] | [PubMed]
 
Warden  DL;  Gordon  B;  McAllister  TW  et al; Neurobehavioral Guidelines Working Group:  Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury.  J Neurotrauma 2006; 23:1468–1501
[CrossRef] | [PubMed]
 
Thompson  CE;  Taylor  FB;  McFall  ME  et al:  Non-nightmare distressed awakenings in veterans with posttraumatic stress disorder: response to prazosin.  J Trauma Stress 2008; 21:417–420
[CrossRef] | [PubMed]
 
Peskind  ER;  Bonner  LT;  Hoff  DJ  et al:  Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder.  J Geriatr Psychiatry Neurol 2003; 16:165–171
[CrossRef] | [PubMed]
 
Germain  A;  Richardson  R;  Moul  DE  et al:  Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances in U.S. military veterans.  J Psychosom Res 2012; 72:89–96
[CrossRef] | [PubMed]
 
Raskind  MA;  Thompson  C;  Petrie  EC  et al:  Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder.  J Clin Psychiatry 2002; 63:565–568
[CrossRef] | [PubMed]
 
Blake  DD;  Weathers  FW;  Nagy  LM  et al:  The development of a clinician-administered PTSD scale.  J Trauma Stress 1995; 8:75–90
[CrossRef] | [PubMed]
 
Weathers  FW;  Ruscio  AM;  Keane  TM:  Psychometric Properties of Nine Scoring Rules for the Clinician-Administered Posttraumatic Stress Disorder Scale.  Psychol Assess 1999; 11:124–133
[CrossRef]
 
Guy  W (ed):  ECDEU Assessment Manual for Psychopharmacology (publication ADM 76-338) .  Washington, DC,  U.S. Department of Health, Education, and Welfare, 1976
 
Pietrzak  RH;  Goldstein  RB;  Southwick  SM  et al:  Personality disorders associated with full and partial posttraumatic stress disorder in the U.S. population: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.  J Psychiatr Res 2011; 45:678–686
[CrossRef] | [PubMed]
 
Pietrzak  RH;  Goldstein  RB;  Southwick  SM  et al:  Medical comorbidity of full and partial posttraumatic stress disorder in US adults: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.  Psychosom Med 2011; 73:697–707
[CrossRef] | [PubMed]
 
References Container
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Articles
Books
APA Practice Guidelines > Chapter 17.  >
DSM-5™ Clinical Cases > Chapter 16.  >
APA Practice Guidelines > Chapter 17.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 56.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 12.  >
Topic Collections
Psychiatric News
APA Guidelines